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An Alternative Treatment for Annular Rupture?Nicolas Piliero, MSC,* Fréderic Thony, MD,*y Gerald Vanzetto, MD, PHD,*z Gilles Barone-Rochette, MD, PHD*zA 96-year-old man was referred to our cardiol-ogy center for a transcatheter aortic valvereplacement (TAVR). Pre-implantation trans-
thoracic echocardiography showed preserved ejection
fraction, mean transvalvular pressure gradient at
46 mm Hg, aortic valve area of 1 cm2, and maximal
aortic jet velocity at 4.1 m/s, conﬁrming severe aortic
stenosis. Aortic annulus diameter was 25 mm as
measured by transesophageal echocardiography, and
its surface was 671 mm2 by 3-dimensional multidetec-
tor computed tomography (Figures 1A and 1B). A
29-mm Sapiens XT valve (Edwards Lifesciences,
Irvine, California) was implanted using left trans-
femoral access. During prosthetic valve deployment,
contrast extravasation into the pericardium occurred
(Figure 1C) causing cardiac shock and pericardial tam-
ponade demonstrated by transthoracic echocardiog-
raphy. Percutaneous pericardiocentesis and ﬂuid
infusion were immediately performed allowing hemo-
dynamic stabilization. Tissue glue composed of a
1/1 mixture of N-butyl-2-cyanoacrylate (Histoacryl)
and Lipiodol (B. Braun, Melsungen, Germany) was
injected into the perforation using a Progreat micro-
catheter (Terumo Corporation, Tokyo, Japan) intro-
duced through a 6-F Amplatz left guiding catheter
(Medtronic, Dublin, Ireland) (Figure 1D). This success-
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further complications. The patient was discharged 5
days after the valve deployment.
Aortic rupture occurs in about 1% of all TAVR im-
plantations (1,2). Potential causes include radial
forces during valve deployment inducing tissue
overdistention along with calciﬁcation of the annulus
and/or valve leaﬂets (1). Depending on the severity
and location of the perforation, treatment can
include: cardiac surgery, isolated percutaneous peri-
cardiocentesis, or a conservative strategy (1). N-butyl-
2-cyanoacrylate is a tissue glue that has the capacity
to harden immediately when in contact with blood.
The adjunction of oily radiopaque substance (Lip-
iodol) delays polymerization and allows radiopacity
(3). Thus, reported here is a novel potential treatment
for aortic rupture during TAVR by an endovascular
approach.
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FIGURE 1 Computed Tomography and Angiography Imagery Before and During TAVR Procedure
(A and B) Pre-operative computed tomography showed massive calciﬁcation on the aortic valve annulus and left anterior leaﬂet
(yellow arrow). (C) A severe contrast extravasation (yellow arrows) was identiﬁed during angiography after transcatheter aortic valve
implantation. (D) Tissue glue was injected into the perforation with a microcatheter. (E) Severe contrast extravasation was stopped successfully
by liquid embolization mixtures.
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